Globus Medical, Inc.

NYSE:GMED Lagerbericht

Marktkapitalisierung: US$9.3b

Globus Medical Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Globus Medical wird ein jährliches Gewinn- und Umsatzwachstum von 40.7% bzw. 11.2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 39.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10.2% betragen.

Wichtige Informationen

40.7%

Wachstumsrate der Gewinne

39.8%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum16.7%
Wachstumsrate der Einnahmen11.2%
Zukünftige Eigenkapitalrendite10.2%
Analystenabdeckung

Good

Zuletzt aktualisiert26 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

Jun 28
Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Apr 08
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Mar 20
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock

Feb 27

Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Feb 09
Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Jan 17
Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Globus Medical: Merger Overhang Lingering

Nov 27

Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Nov 14
Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Oct 27
Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Globus Medical: Almost Having My Back

Sep 13

Globus Medical: Slightly Too Pricey Right Now

Aug 07

Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy

Jul 18

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jul 11
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Jun 18
Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Apr 09
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Mar 22
What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Feb 24
Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Globus Medical Q4 2022 Earnings Preview

Feb 20

Globus Medical: An Impressive Long-Term Revenue Growth Play

Jan 08

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Dec 22
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Dec 01
Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line

Nov 08

A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Oct 15
A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact

Sep 02

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Sep 02
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Aug 11
Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective

Jun 05

Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

May 24
Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

May 06
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Mar 14
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Globus Medical Continues To Flex Its Innovation Muscles To Drive Share Growth

Mar 01

Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Feb 24
Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Feb 08
Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jan 21
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Gewinn- und Umsatzwachstumsprognosen

NYSE:GMED - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20262,848453N/AN/A10
12/31/20252,652381678N/A14
12/31/20242,475227239N/A14
3/31/20241,89867152243N/A
12/31/20231,568123165243N/A
9/30/20231,226158129203N/A
6/30/20231,097204121185N/A
3/31/20231,069201117187N/A
12/31/20221,023190104178N/A
9/30/2022998155118191N/A
6/30/2022974155157235N/A
3/31/2022961142194257N/A
12/31/2021958149219276N/A
9/30/2021942187226280N/A
6/30/2021928184203256N/A
3/31/2021826122165220N/A
12/31/2020789102135199N/A
9/30/202076795108173N/A
6/30/202074789115176N/A
3/31/2020793148110175N/A
12/31/2019785155101172N/A
9/30/201977014690162N/A
6/30/201974314382158N/A
3/31/201972215093169N/A
12/31/2018713156122182N/A
9/30/2018693144126182N/A
6/30/2018676134112165N/A
3/31/2018655118106158N/A
12/31/2017636107N/A159N/A
9/30/2017612107N/A166N/A
6/30/2017595108N/A174N/A
3/31/2017581105N/A171N/A
12/31/2016564104N/A148N/A
9/30/2016553118N/A166N/A
6/30/2016554118N/A153N/A
3/31/2016548116N/A143N/A
12/31/2015537113N/A124N/A
9/30/2015518103N/A80N/A
6/30/201549999N/A85N/A
3/31/201548196N/A85N/A
12/31/201446792N/A79N/A
9/30/201445486N/A110N/A
6/30/201444383N/A108N/A
3/31/201443670N/A104N/A
12/31/201342769N/A93N/A
9/30/201342068N/A86N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: GMEDDas prognostizierte Gewinnwachstum (40.7% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: GMEDDie Erträge des Unternehmens (40.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.8% pro Jahr).

Hohe Wachstumserträge: GMEDEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: GMEDDie Einnahmen des Unternehmens (11.2% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.7% pro Jahr).

Hohe Wachstumseinnahmen: GMEDDie Einnahmen des Unternehmens (11.2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: GMEDDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.2 %).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y